The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Three‐Month Tolerability of Orlistat in Adolescents with Obesity‐Related Comorbid Conditions
Open accessAbstract
Objective:To study the safety, tolerability, and potential efficacy of orlistat in adolescents with obesity and its comorbid conditions. Research Methods and Procedures:We studied 20 adolescents (age, 14.6 ± 2.0 years; body mass index, 44.1 ± 12.6 kg/m 2). Subjects were evaluated before and after taking orlistat (120 mg three times daily) and a multivitamin for 3 months. Subjects were simultaneously enrolled in a 12‐week program emphasizing diet, exercise, and strategies for behavior change. Results:Participants who completed treatment (85%) reported taking 80% of prescribed medication. Adverse effects were generally mild, limited to gastrointestinal effects observed in adults, and decreased with time. Three subjects required additional vitamin D supplementation despite the prescription of a daily multivitamin containing vitamin D. Weight decreased significantly (−4.4 ± 4.6 kg,p< 0.001; −3.8 ± 4.1% of initial weight), as did body mass index (−1.9 ± 2.5 kg/m 2;p< 0.0002). Total cholesterol (−21.3 ± 24.7 mg/dL;p< 0.001), low‐density lipoprotein‐cholesterol (−17.3 ± 15.8 mg/dL;p< 0.0001), fasting insulin (−13.7 ± 19.0 μU/mL;p< 0.02), and fasting glucose (−15.4 ± 7.4 mg/dL;p< 0.003) were also significantly lower after orlistat. Insulin sensitivity, assessed by a frequently sampled intravenous glucose‐tolerance test, improved significantly (p< 0.02). Discussion:We conclude that, in adolescents, short‐term treatment with orlistat, in the context of a behavioral program, is well‐tolerated and has a side‐effect profile similar to that observed in adults, but its true benefit versus conventional therapy remains to be determined in placebo‐controlled trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term maintenance of weight loss: Current status.
Jeffery, R. W., Epstein, L. H., Wilson, G. T., Drewnowski, A., Stunkard, A. J., & Wing, R. R. (2000) · Health Psychology · doi:10.1037/0278-6133.19.suppl1.5 · Cited by 1,093
Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach
Bergman, R. N. (1989) · Diabetes · doi:10.2337/diab.38.12.1512 · Cited by 1,001
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947 · cited 1×
“Orlistat is minimally absorbed (27) and has few known adverse effects of consequence in adults (18); therefore, it has the potential for a favorable risk-benefit ratio in children and adolescents.”
A new air displacement method for the determination of human body composition
DEMPSTER, P., & AITKENS, S. (1995) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199512000-00017 · Cited by 678
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Orlistat in the long-term treatment of obesity in primary care settings.
Hauptman, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.160 · Cited by 367
Orlistat Inhibits Dietary Cholesterol Absorption
Mittendorfer, B., Ostlund, R. E., Patterson, B. W., & Klein, S. (2001) · Obesity Research · doi:10.1038/oby.2001.79 · Cited by 114
Incorrect use and limited weight reduction of orlistat (Xenical) in clinical practice
Beermann, B., Melander, H., Säwe, J., Ulleryd, C., & Dahlqvist, R. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100316 · Cited by 11
Cited by
Barlow, S. E., & and the Expert Committee (2007) · Pediatrics · doi:10.1542/peds.2007-2329c · Cited by 4,497
Overweight in Children and Adolescents: Pathophysiology, Consequences, Prevention, and Treatment
Daniels, S. R., Arnett, D. K., Eckel, R. H., Gidding, S. S., Hayman, L. L., Kumanyika, S., Robinson, T. N., Scott, B. J., St. Jeor, S., & Williams, C. L. (2005) · Circulation · doi:10.1161/01.cir.0000161369.71722.10 · Cited by 1,550
Styne, D. M., Arslanian, S. A., Connor, E. L., Farooqi, I. S., Murad, M. H., Silverstein, J. H., & Yanovski, J. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2573 · Cited by 1,282
Self-citationKelly, A. S., Barlow, S. E., Rao, G., Inge, T. H., Hayman, L. L., Steinberger, J., Urbina, E. M., Ewing, L. J., & Daniels, S. R. (2013) · Circulation · doi:10.1161/cir.0b013e3182a5cfb3 · Cited by 980
Recommendations for Treatment of Child and Adolescent Overweight and Obesity
Spear, B. A., Barlow, S. E., Ervin, C., Ludwig, D. S., Saelens, B. E., Schetzina, K. E., & Taveras, E. M. (2007) · Pediatrics · doi:10.1542/peds.2007-2329f · Cited by 856
Metadata
- Authors
- McDuffie, J. R., Calis, K. A., Uwaifo, G. I., Sebring, N. G., Fallon, E. M., Hubbard, V. S., & Yanovski, J. A.
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 10
- Issue
- 7
- Pages
- 642-650
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W2104748338
- Cited by
- 183
- References
- 8
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.